Talk:Ecamsule
From Wikipedia, the free encyclopedia
 |
This article is within the scope of WikiProject Medicine. Please visit the project page for details or ask questions at the doctor's mess. |
| Start | This page has been rated as Start-Class on the quality assessment scale |
| Low | This article has been rated as Low-importance on the importance assessment scale |
 |
Ecamsule is part of WikiProject Pharmacology, a project to improve all Pharmacology-related articles. If you would like to help improve this and other pharmacology articles, please join the project. All interested editors are welcome. |
| Stub | This article has been rated as stub-Class on the quality scale. |
|
|
|
 |
Please help improve this article or section by expanding it. Further information might be found on the talk page or at requests for expansion. (January 2007) |
Contents |
[edit] UVA vs. UVB
72.1.206.20 corrected my original mistake.
From the EPA: "Two types of UV radiation reach the Earth's surface: UVA and UVB. UVB is usually associated with sunburn while UVA is recognized as a deeper penetrating radiation." --betakate 16:16, 13 December 2005 (UTC)
[edit] FDA approval
Sunscreens based on mexoryl have been available in Canada, Europe and other parts of the world since 1993, but it is still awaiting FDA approval for sale in the United States.
- Considering the fact that dozens of new drugs have been developed and aproved for use in the US since 1993, could someone explain why a safe and effective sunscreen like Mexoryl has not been approved, or expand this article to include the circumstances and status of approval? —Viriditas | Talk 12:12, 22 May 2006 (UTC)
- There may have been dozens of drugs approved since 1993, but that's dozens out of how many? Plenty of American drug candidates make it to the pre-approval stage and never get approved. The FDA approval process is one of the most stringent processes in the world, in part because the manufacturer must show that the drug is safe throughout a wide range of concentrations, must document the pharmacokinetics and bioavailability of the drug, must ensure that the drug gains no unexpected reactivity with exposure to UV radiation, etc. A delay in approval is far from the exception, it's actually far more typical for a drug candidate to be delayed rather than to be given a quick green light. --chodges 06:05, 29 June 2006 (UTC)
[edit] Requested move
Mexoryl → Ecamsule – Mexoryl® is a trade name. — Talk:Mexoryl — Fvasconcellos 19:43, 24 July 2006 (UTC) copied from the entry on the WP:RM page
[edit] Survey
- Add *Support or *Oppose followed by an optional one-sentence explanation, then sign your opinion with ~~~~
oppose Ecamsule is already an article. I think a merger is a better choice. --Edgelord 05:55, 31 July 2006 (UTC)
[edit] Discussion
- Strong support. I was just about to perform the move myself when I came here. Alvis 21:07, 29 July 2006 (UTC)
- Support justo 22:10, 31 July 2006 (UTC)
- Re merge. The material already appears to have been merged. Vegaswikian 00:21, 2 August 2006 (UTC)
This article has been renamed as the result of a move request. Vegaswikian 00:21, 2 August 2006 (UTC)
[edit] WikiProject class rating
This article was automatically assessed because at least one WikiProject had rated the article as stub, and the rating on other projects was brought up to Stub class. BetacommandBot 16:25, 10 November 2007 (UTC)
